# AMBRISENTAN
> **ANDA208252** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2019-03-28
## Drug
- **FDA Application Number:** ANDA208252
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMBRISENTAN
- **Generic name:** AMBRISENTAN
- **Active ingredients:** AMBRISENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS INC
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2019-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208252)
---
*AI Analytics · CC0 1.0*